FV Pharma's pharmaceutical-grade cannabis products will be made from the flowering head, or the female Cannabis sativa spp. indica plant once the company receives the licence to grow medical marihuana. The cannabis plant material is dried under strict conditions to ensure proper curing of the herbal material while lessening the chance of contamination and fungal opportunity. Moisture content is monitored for consistency and to ensure appropriate usability and stability of the stored product. The cannabis plant material is milled to create a homogenous product for consistency of dosage. Dose consistency is required for research and therapeutic purposes, allowing the overseeing healthcare practitioner to be confident in the level of THC (delta-9-tetrahydrocannabinol) and/or CBD (cannabidiol) the patient is receiving.
FV Pharma's pharmaceutical-grade cannabis products are packaged in child-proof, tamper evident containers compliant with the Canadian Standards Association (CSA) and the Food and Drugs Act (FDA). When it comes to producing medical marihuana we are absolute leaders. We set the standard for every aspect of the growing environment in order to generate consistent characteristics and desired results for every strain we cultivate. At our state-of-the-art, purpose-built testing facility, we're focused on ongoing research and constant refinement of our processes. We've implemented the highest standard of quality assurance with a goal to exceed strict compliance with Health Canada regulations. This ensures that what you receive is high quality, pharmaceutical-grade products that are both safe and effective for your treatment.
Link to Current Authorized Producers under MMPR: